Is UAMY a Buy or a Sell? The Bull and Bear Case (2026)
Last updated July 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for United States Antimony Corporation (UAMY) rests on The tripled Montana smelter: The Thompson Falls expansion cost ~$39M, was substantially completed during the second quarter of 2026, and is expected to more than triple the facility's antimony processing capacity. The bear case rests on the antimony price cycle dominates everything. Analysts covering it publish targets from $9.00 to $13.50 against a $5.20 price, so even the professionals disagree by 40% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
United States Antimony Corporation (NYSE: UAMY, also listed on NYSE Texas) has been processing antimony in Montana since 1970 and moved from NYSE American to the New York Stock Exchange in March 2026. It reports two segments. The antimony segment covers the Thompson Falls smelter in Sanders County, Montana, which turns ore into antimony oxide, metal ingots, trisulfide and a small stream of gold and silver, plus the Madero smelter in Mexico run through its USAMSA subsidiary. The zeolite segment is Bear River Zeolite in Preston, Idaho, which surface mines and sells zeolite for water filtration, soil amendment and animal feed. Around those two segments sits a widening set of early-stage assets: the restarted Stibnite Hill mine and the new Radersburg flotation mill in Montana, claims at Nolan Creek and in the Fairbanks District of Alaska, the Fostung tungsten project in Ontario, and a hydrometallurgical joint venture with Americas Gold and Silver in Idaho. The company employed ~100 full-time staff at the end of 2025. The financial picture turned sharply in 2026. Revenue for the twelve months through June was ~$36.4M, up from ~$14.9M in 2024, but the second quarter brought ~$7.9M against ~$10.5M a year earlier because realized antimony prices fell ~52% to ~$13.70 per pound. Gross margin compressed to ~7% from ~27%, and operating expenses roughly tripled to ~$7.6M on stock compensation and a larger payroll, producing a ~$7.0M operating loss that a ~$6.8M paper gain on the company's Larvotto Resources stake happened to offset. The balance sheet is unusually strong for a company this size: ~$62.2M of cash and Treasuries, a ~$43.2M equity stake in Larvotto, ~$70.0M of working capital and almost no debt. The central question is arithmetic: a ~$778M market value on ~$36.4M of trailing revenue and a ~$16.3M trailing net loss assumes the tripled Thompson Falls capacity, the DLA contract and self-mined feedstock convert into much higher revenue at margins the last two quarters have not shown.
The bull case: what would have to be true for $13.50
The most optimistic published target on UAMY is $13.50, +159.6% from the $5.20 price as of August 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. The tripled Montana smelter.
The Thompson Falls expansion cost ~$39M, was substantially completed during the second quarter of 2026, and is expected to more than triple the facility's antimony processing capacity. Roughly ~$12.8M of the cost came back as a milestone payment under a Defense Production Act Title III award from the U.S. Department of War, an award of up to ~$27.0M of which ~$16.2M is currently obligated. Whether that capacity fills is the largest swing factor in the story.
2. Government demand as a floor.
The five-year Defense Logistics Agency contract for antimony metal ingots has begun shipping. The first two shipments of ~82,000 pounds were accepted in July 2026 and put ~$2.6M into third-quarter revenue, with a disclosed schedule of seven shipments totaling ~$9.17M. That is meaningful against a ~$36.4M revenue base and is priced independently of spot antimony. The company has also filed four further grant requests to the Departments of Energy and War totaling ~$275M that have not been awarded.
3. Owning the feedstock.
Gross margin during the first half of 2026 got no help from company-mined ore because everything sold was bought from third parties. Stibnite Hill restarted in April 2026 and has moved ~576 tons of ~10% antimony ore at roughly ~42 tons per day, more than double the 2025 pace, feeding the new Radersburg flotation mill. Ore the company mines itself carries a very different cost per pound than ore it buys, so this is where a ~7% gross margin either recovers or does not.
4. Zeolite as the quiet compounder.
Bear River Zeolite grew second-quarter revenue ~110% to ~$1.9M on ~6,609 tons sold, driven by cattle nutrition and wider industrial distribution. Reserves of ~5.1 million short tons against production near ~12,000 tons a year imply decades of runway. It is small next to antimony and its margins are thin, but it grows without depending on a volatile metal price, in a business where the three largest customers accounted for ~80% of 2025 sales.
The bear case: what would have to be true for $9.00
The most pessimistic published target is $9.00, +73.1% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks United States Antimony Corporation is worth if the risks below bite instead of the drivers above.
The antimony price cycle dominates everything. European assessments peaked near ~$59,750 per tonne in July 2025 and had fallen to roughly ~$23,000 by mid-2026, which is why UAMY shares trade near ~$5.20 against a 52-week range of ~$4.14 to ~$19.71. Dilution has been heavy: shares outstanding went from ~108 million in mid-2024 to ~150.5 million at June 2026, including ~$49.1M of net equity issuance in the first half of 2026 at an average of ~$11.56 per share, well above the current quote. Share-based compensation of ~$7.7M in six months is large against ~$14.7M of revenue, and reported net income now swings on the mark-to-market value of the Larvotto stake rather than on operations. Customer concentration and Mexican operating exposure are also disclosed.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding UAMY already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on UAMY
4 analysts cover UAMY, with an average target of $11.19 (+115.2% against $5.20) and a split of 4 buy, 0 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the UAMY forecast and price target page.
How is UAMY valued? (as of August 2026)
Snapshot for UAMY as of August 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$36.4M
- Q2 2026 revenue: ~$7.9M, down from ~$10.5M
- Q2 2026 gross margin: ~7%, down from ~27%
- Net loss (TTM): ~$16.3M
- Cash, Treasuries and Larvotto stake: ~$105M, with almost no debt
- Market value / trailing sales: ~21x on a ~$778M market value
The valuation rests on capacity and contracts rather than current output. Full-year 2025 revenue of ~$39.3M was itself inflated by peak antimony pricing, and the first half of 2026 came in at ~$14.7M against ~$17.5M a year earlier. Management authorized a ~$100M share repurchase on 19 August 2026, saying the board considered the stock undervalued, four months after raising ~$49.1M of equity.
How do you decide if UAMY is a buy?
Rather than asking whether UAMY is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold UAMY indirectly through an index or sector ETF before adding more.
What would change your mind on UAMY
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: The tripled Montana smelter stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: the antimony price cycle dominates everything fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the UAMY stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about UAMY against your real portfolio and see your actual exposure before deciding.
Investing in United States Antimony Corporation with AI
Connect the broker you already use and ask Walnut's AI how UAMY fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is UAMY a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on The tripled Montana smelter, with revenue (ttm) at ~$36.4M. The bear case rests on the antimony price cycle dominates everything. Analysts covering it are spread from $9.00 to $13.50, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell UAMY?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The antimony price cycle dominates everything. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $9.00, +73.1% from the $5.20 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for UAMY?
+
The tripled Montana smelter. The Thompson Falls expansion cost ~$39M, was substantially completed during the second quarter of 2026, and is expected to more than triple the facility's antimony processing capacity. The most optimistic analyst target on UAMY is $13.50, +159.6% from the $5.20 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for UAMY?
+
The antimony price cycle dominates everything. European assessments peaked near ~$59,750 per tonne in July 2025 and had fallen to roughly ~$23,000 by mid-2026, which is why UAMY shares trade near ~$5.20 against a 52-week range of ~$4.14 to ~$19.71. Dilution has been heavy: shares outstanding went from ~108 million in mid-2024 to ~150.5 million at June 2026, including ~$49.1M of net equity issuance in the first half of 2026 at an average of ~$11.56 per share, well above the current quote. Share-based compensation of ~$7.7M in six months is large against ~$14.7M of revenue, and reported net income now swings on the mark-to-market value of the Larvotto stake rather than on operations. Customer concentration and Mexican operating exposure are also disclosed. The most pessimistic published target is $9.00, +73.1% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does United States Antimony Corporation do?
+
The only fully integrated antimony miner, smelter and refiner outside China and Russia, with Montana and Mexico smelters plus an Idaho zeolite mine.
What would have to change for UAMY to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (The tripled Montana smelter) stalling in the reported numbers rather than in the narrative, the risk above (the antimony price cycle dominates everything) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does United States Antimony Corporation actually do?
+
It mines, buys and processes antimony ore into finished products including antimony oxide, metal ingots and trisulfide, at a smelter in Thompson Falls, Montana and a second smelter in Mexico. It also mines and sells zeolite from Bear River Zeolite in Preston, Idaho. The company describes itself as the only fully integrated antimony operation outside China and Russia. Antimony sits on the U.S. Critical Minerals List because of its use in flame retardants, ammunition primers and batteries.
Why has UAMY stock fallen so far from its highs?
+
The share price tracks the antimony price, which spiked after China imposed export controls in late 2024 and then corrected hard. European assessments went from roughly ~$15,000 to ~$18,000 per tonne before the controls, to a peak near ~$59,750 in July 2025, back to about ~$23,000 by mid-2026. UAMY's own realized price fell ~52% year over year to ~$13.70 per pound in the second quarter of 2026, and the stock now trades near ~$5.20 against a 52-week high of ~$19.71.
Is UAMY profitable?
+
Not from operations. The company reported a ~$7.0M operating loss in the second quarter of 2026 and a ~$14.5M operating loss for the first half. Second-quarter net income of ~$0.1M came almost entirely from a ~$6.8M unrealized gain on the company's shareholding in Larvotto Resources plus ~$0.4M of investment income. Over the trailing twelve months the net loss is ~$16.3M on ~$36.4M of revenue.
Walnut is informational, not investment advice, and gives no verdict on UAMY. Analyst targets referenced here come from a August 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.